Molteno A C, Haddad P J
Aust N Z J Ophthalmol. 1985 Nov;13(4):329-35. doi: 10.1111/j.1442-9071.1985.tb00443.x.
The visual outcome of cases of neovascular glaucoma treated by draining implants has improved from 12% to 32% of eyes achieving a vision of 6/60 or better. The main factor responsible for this improvement has been the recognition that, in neovascular glaucoma, the retinal blood vessels are not capable of autoregulation of calibre in response to changes in intraocular pressure and ophthalmic artery perfusion pressure. The consequences of this situation are discussed and the importance of early treatment of neovascular glaucoma by a combination of photocoagulation, insertion of a draining implant and medical measures to improve the circulation where possible is emphasized.
采用引流植入物治疗的新生血管性青光眼病例的视觉预后得到了改善，视力达到6/60或更好的眼睛比例从12%提高到了32%。这种改善的主要原因是认识到，在新生血管性青光眼中，视网膜血管无法根据眼压和眼动脉灌注压的变化自动调节管径。文中讨论了这种情况的后果，并强调了通过光凝、插入引流植入物以及在可能的情况下采取改善循环的药物措施对新生血管性青光眼进行早期治疗的重要性。
